regulatory is the most under-discussed thing in c/vendorvetting
sequence. That is the whole post, but I will justify it. Everything else people worry about in c/labresults is downstream of it. Titration speed, early fullness, the endless dose arguments — most of it resolves if you sort sequence out first, and almost nobody does. I say this having got it wrong for 22 months. My…
handlers in the community are rare and cautious
handlers in the community are rare and cautious
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
near-zero controlled human data, full stop
Which country? Half the answers in this thread only apply in Denmark.
Respectfully this is a sample of one presented as a finding.
This is the "correlation is mechanism" thing again. You changed three variables at once.
rodent data must be labelled as rodent data
tendon and rodent data literature in rodents is interesting
rodent data must be labelled as rodent data
This is correct. The naming is genuinely confusing.
near-zero controlled human data, full stop
Disagree. What you are describing is consistent with pentadecapeptide, not with what you concluded.
near-zero controlled human data, full stop